Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer - Test2 - elhamkhani - TriplyDB

Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer

Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer

http://www.wikidata.org/entity/Q34215504

about

Preoperative serum pre-albumin as an independent prognostic indicator in patients with localized upper tract urothelial carcinoma after radical nephroureterectomy A novel inflammation-based prognostic score in esophageal squamous cell carcinoma: the C-reactive protein/albumin ratio.Albumin and Neutrophil Combined Prognostic Grade as a New Prognostic Factor in Non-Small Cell Lung Cancer: Results from a Large Consecutive Cohort Pretreatment Neutrophil to Lymphocyte Ratio Is Associated with Poor Survival in Patients with Stage I-III Non-Small Cell Lung Cancer Prealbumin/CRP Based Prognostic Score, a New Tool for Predicting Metastasis in Patients with Inoperable Gastric Cancer.Cancer-related inflammation as predicting tool for treatment outcome in locally advanced and metastatic non-small cell lung cancer.Pretreatment neutrophil-to-lymphocyte ratio and its dynamic changes are associated with the overall survival in advanced cancer patients undergoing palliative care Distinct transcriptional changes in non-small cell lung cancer patients associated with multi-antigenic RNActive® CV9201 immunotherapy.Analysis of the immune microenvironment in resected non-small cell lung cancer: the prognostic value of different T lymphocyte markers.Prognostic value of the C-reactive protein/albumin ratio in patients with laryngeal squamous cell carcinoma.Downregulation of the neonatal Fc receptor expression in non-small cell lung cancer tissue is associated with a poor prognosis.Strategies for clinical implementation of TNM-Immunoscore in resected nonsmall-cell lung cancer.Role of the Immune Response in Disease Progression and Therapy in Multiple Myeloma.Neutrophil-to-Lymphocyte Ratio Predicts Outcome in Limited Disease Small-cell Lung Cancer.Progress in the application and mechanism of metformin in treating non-small cell lung cancer.Platelet-to-Lymphocyte Ratio and Use of NSAIDs During the Perioperative Period as Prognostic Indicators in Patients With NSCLC Undergoing Surgery.A new score for screening of malnutrition in patients with inoperable gastric adenocarcinoma.Repurposing Drugs in Oncology (ReDO)-clarithromycin as an anti-cancer agent Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis.Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Ca Pre-treatment inflammatory indexes as predictors of survival and cetuximab efficacy in metastatic colorectal cancer patients with wild-type RAS.Evaluation of a prognostic scoring system based on the systemic inflammatory and nutritional status of patients with locally advanced non-small-cell lung cancer treated with chemoradiotherapy.Prognostic significance of immune-nutritional parameters for surgically resected elderly lung cancer patients: a multicentre retrospective study.Pretreatment advanced lung cancer inflammation index (ALI) for predicting early progression in nivolumab-treated patients with advanced non-small cell lung cancer.Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer.Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in gastric cancer.Nutritional status and muscle dysfunction in chronic respiratory diseases: stable phase versus acute exacerbations.Prognostic significance of immune cells in non-small cell lung cancer: meta-analysis.Sarcopenia in resected non-small cell lung cancer: let's move to patient-directed strategies Anticancer Therapy-Induced Atrial Fibrillation: Electrophysiology and Related Mechanisms

P2860

Q33829648-7020F726-0FAC-4B96-98B6-CA1AC799F67A Q35579236-0D548053-490E-4BF9-A944-9A6654156C5F Q35866244-9F2F6B7E-ABFC-4F8F-99DC-9B53A2DFA20A Q36151154-0A93A1E4-7EA3-4EA4-BF54-9822DBD85767 Q36557940-73ACEC55-B7F1-4C88-895C-8F3CA102CF8B Q37121339-9C61775F-FD80-4002-8E6D-71D31CE5B7F3 Q37166986-C5BC601B-9032-41A4-8BD2-27F60971ABB7 Q37559326-6C01AA6F-1B31-433F-B978-C38E10E6CB90 Q37619675-4A7B0098-82CF-4FD9-8D83-A117A0157411 Q37652983-1E3A3B6A-8F7F-442E-B550-F3135A492F66 Q37688076-2A049550-3BE2-49E0-B31A-EE47A17D9590 Q38636708-FC8EAE51-DDB0-4AD2-B880-B6DA0F13A4E9 Q38815399-D97AF9C9-C37C-4CF6-A795-F3196D8619E0 Q38982694-BB211725-78EE-4664-8D3C-C8F45963CFA3 Q39321321-6AAB680F-6D18-4BE4-8F5C-7F8AA98F5EF4 Q39458282-6B638747-B1A0-42AC-B774-DFCF746F06DA Q40277596-927366CE-46CE-4379-9AFC-0134DD03F6C1 Q41327770-432D62C9-6C4F-47E8-A169-65487C79107B Q41492181-311DFDD2-CBF4-4617-AEF4-75B6ED2665A6 Q46540302-2A5D2567-68F9-414E-93F9-F58CA9288439 Q47105389-81631B52-BC8F-44D9-832E-8F258EF22FA4 Q47356300-735D0443-50AD-4C55-95B2-0E297455311F Q47739152-B96FD613-2C78-4775-9C11-16333FE34A02 Q48278429-C6B63BB7-A34F-453A-B75F-E268EBDFA8E3 Q51482020-03BC5CB4-BCD7-456E-B1D9-8A13DE3B1FCB Q52645244-20BF7270-8CE4-44E9-A116-991851441FD1 Q55212210-E107DD46-8BF0-424A-8379-44157861B977 Q55440274-55B8B6FC-8F21-4052-A00E-C963F4FB8FBD Q58128727-EBCB62C6-14C8-4462-8307-EECC1D1B4F1E Q58554222-BA57C152-8C66-413A-A9A6-FE359F7311BA

P2860

Systemic inflammation, nutritional status and tumor immune microenvironment determine outcome of resected non-small cell lung cancer

http://www.wikidata.org/entity/Q34215504

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Systemic inflammation, nutriti ...... ted non-small cell lung cancer

@ast

Systemic inflammation, nutriti ...... ted non-small cell lung cancer

@en

Systemic inflammation, nutriti ...... ted non-small cell lung cancer

@nl

type

label

Systemic inflammation, nutriti ...... ted non-small cell lung cancer

@ast

Systemic inflammation, nutriti ...... ted non-small cell lung cancer

@en

Systemic inflammation, nutriti ...... ted non-small cell lung cancer

@nl

prefLabel

Systemic inflammation, nutriti ...... ted non-small cell lung cancer

@ast

Systemic inflammation, nutriti ...... ted non-small cell lung cancer

@en

Systemic inflammation, nutriti ...... ted non-small cell lung cancer

@nl

P1433

Q34215504-5A8EC5C9-BD11-4B44-BC2D-9BBBF780836E

P1476

Q34215504-E11CF659-029E-4186-8EED-0498BA0A7B5B

P2093

Q34215504-06E734EE-4A74-410E-BAC0-D17E48D76E6B

Q34215504-135B03F2-CF91-4A65-A252-1643A7BA8D6C

Q34215504-42547C66-3346-4ED9-92C4-8F1CFF044A2B

Q34215504-42FCE141-F13F-4CAF-8E09-BDE5293F25A9

Q34215504-45CB7902-6B16-4A6E-863F-2C3D71F657B6

Q34215504-5826ECC8-AA02-4B3A-8DDB-659797FB30B3

Q34215504-5AFEC9FB-EE3F-4857-94C0-C8610D2FE87C

Q34215504-778EFD3F-0D25-4C16-AF41-7A14908E6079

Q34215504-B315E22D-E165-44A8-BD10-6E7C8551233B

Q34215504-C9FA9337-9140-4961-8844-FDB7315B6ADF

P2860

Q34215504-00328726-E83E-4D5B-AECB-6CA4B0C9E6DE

Q34215504-03DAD8BD-3421-4283-9123-74B82AD7493C

Q34215504-0489D88A-4A04-4C1A-91E2-4B47C8E8BC86

Q34215504-0ABE97BE-9C42-4926-A4F3-B1B4B79DE60F

Q34215504-232493F2-B2BD-4024-BFC5-DB5A43AD8F14

Q34215504-2FE3B0B3-9F74-4693-9E81-13D71BA9C97C

Q34215504-369ACE70-BEF6-4218-A3A2-280D31E9E491

Q34215504-5ADFFFF5-FE09-4BDE-8555-EDE48CDA0DB2

Q34215504-5CEFA0FA-25D4-485A-A52C-01B8C7480AD7

Q34215504-872550B1-BD5D-4900-ACDF-926FA27095EC

P304

Q34215504-1C41B0D5-86CE-4933-9D4E-60C70082ABC5

P31

Q34215504-F42E36BE-00D7-4808-88E7-1BDBD9CB7EB6

P356

Q34215504-386E403A-F749-4194-8FAC-1E76B0982C22

P407

Q34215504-D54CBCFA-5083-47EC-A8BF-A2472625DD68

P433

Q34215504-06407C44-4EF2-4524-AE20-733BA0A5BA76

P478

Q34215504-2BABC92C-989E-4D53-BA71-65416BB8973F

P50

Q34215504-4754CA0B-1E55-4FEA-90DB-144C3E9CB02A

Q34215504-8F86EE76-FC80-4475-A37E-2C48ED8420C4

Q34215504-9E8B34C3-892E-41B5-8431-070DAAD28453

Q34215504-DE4D8CB6-043C-41C4-B3B0-C69684B04805

Q34215504-EC9A1F95-E212-4093-A5A1-6C6C287E8363

P577

Q34215504-40D22F8F-96C2-4F96-8CE7-A64E4C970047

P5875

Q34215504-672FF00D-596B-4522-8F09-6B1CF7406C3C

P698

Q34215504-A40F34D6-CB85-4E37-A423-FC7B9B3C1955

P932

Q34215504-B1D40866-9719-45D2-A944-36B238CABB5D

P356

JOURNAL.PONE.0106914

P1433

P1476

Systemic inflammation, nutriti ...... ted non-small cell lung cancer

@en

P2093

Antonio Bobbio

http://www.w3.org/2001/XMLSchema#string

Audrey Mansuet-Lupo

http://www.w3.org/2001/XMLSchema#string

Barbara Burroni

http://www.w3.org/2001/XMLSchema#string

Emelyne Canny

http://www.w3.org/2001/XMLSchema#string

Filippo Lococo

http://www.w3.org/2001/XMLSchema#string

Hanane Ouakrim

http://www.w3.org/2001/XMLSchema#string

Hervé Dermine

http://www.w3.org/2001/XMLSchema#string

Jean-François Régnard

http://www.w3.org/2001/XMLSchema#string

Jérôme Biton

http://www.w3.org/2001/XMLSchema#string

Marco Alifano

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

C-reactive protein: a critical update

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

The immune contexture in human tumours: impact on clinical outcome

Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial.

Nutrition and the immune system: an introduction.

Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review.

The International Epidemiology of Lung Cancer: geographical distribution and secular trends.

Individualizing chemotherapy for non-small cell lung cancer (NSCLC) in the adjuvant and advanced setting: current status and future directions.

Systemic inflammation, nutritional status and survival in patients with cancer.

P304

e106914

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0106914

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Isabelle Cremer

Marie-Caroline Dieu-Nosjean

P577

2014-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

265859356

http://www.w3.org/2001/XMLSchema#string

P698

25238252

http://www.w3.org/2001/XMLSchema#string

P932

4169516

http://www.w3.org/2001/XMLSchema#string